Shama Bajaj Selected Research

Mesylates (Mesylate)

2/2013	Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs.
1/2013	Diuretic effects of cannabinoids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shama Bajaj Research Topics

Disease

2	Hypothermia 05/2013 - 01/2013
1	Shock 02/2013

Drug/Important Bio-Agent (IBA)

2	9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA 02/2013 - 01/2013
2	Mesylates (Mesylate)IBA 02/2013 - 01/2013
1	SCH 23390IBA 02/2013
1	RimonabantIBA 02/2013
1	Opioid Analgesics (Opioids)IBA 02/2013
1	quinolineIBA 02/2013
1	methanandamideIBA 02/2013
1	AM4113IBA 02/2013
1	Morphine (MS Contin)FDA LinkGeneric 02/2013
1	Naltrexone (ReVia)FDA LinkGeneric 02/2013
1	pyrazoleIBA 02/2013
1	Dopamine (Intropin)FDA LinkGeneric 02/2013
1	Haloperidol (Haldol)FDA LinkGeneric 02/2013
1	Methamphetamine (Desoxyn)FDA LinkGeneric 02/2013
1	CannabinoidsIBA 01/2013
1	3- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA 01/2013
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2013

Therapy/Procedure

2	Analgesia 05/2013 - 01/2013